| Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling BD Robinson, PJ Vlachostergios, B Bhinder, W Liu, K Li, TJ Moss, ... Nature communications 10 (1), 2977, 2019 | 196 | 2019 |
| EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma H Liu, Y Liu, W Liu, W Zhang, J Xu Nature communications 6 (1), 8494, 2015 | 126 | 2015 |
| Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic … Q Wu, HO Liu, YD Liu, WS Liu, D Pan, WJ Zhang, L Yang, Q Fu, JJ Xu, ... Journal of Biological Chemistry 290 (2), 1170-1185, 2015 | 103 | 2015 |
| Polycomb-mediated loss of microRNA let-7c determines inflammatory macrophage polarization via PAK1-dependent NF-κB pathway W Zhang, H Liu, W Liu, Y Liu, J Xu Cell Death & Differentiation 22 (2), 287-297, 2015 | 81 | 2015 |
| Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma L Chen, H Liu, J Liu, Y Zhu, L Xu, H He, H Zhang, S Wang, Q Wu, W Liu, ... PLoS One 8 (3), e58413, 2013 | 59 | 2013 |
| p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma Y Zhu, H Liu, L Xu, H An, W Liu, Y Liu, Z Lin, J Xu Cell death & disease 6 (2), e1637-e1637, 2015 | 51 | 2015 |
| N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation J Liu, H Liu, W Zhang, Q Wu, W Liu, Y Liu, D Pan, J Xu, J Gu Glycobiology 23 (9), 1097-1109, 2013 | 43 | 2013 |
| Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma H Fu, Y Liu, L Xu, W Liu, Q Fu, H Liu, W Zhang, J Xu Tumor Biology 36, 5791-5799, 2015 | 42 | 2015 |
| Decreased expression of SETD2 predicts unfavorable prognosis in patients with nonmetastatic clear-cell renal cell carcinoma W Liu, Q Fu, H An, Y Chang, W Zhang, Y Zhu, L Xu, J Xu Medicine 94 (45), e2004, 2015 | 41 | 2015 |
| High expression of interleukin‐11 is an independent indicator of poor prognosis in clear‐cell renal cell carcinoma D Pan, L Xu, H Liu, W Zhang, W Liu, Y Liu, Q Fu, J Xu Cancer Science 106 (5), 592-597, 2015 | 38 | 2015 |
| Loss of N-acetylgalactosaminyltransferase-4 orchestrates oncogenic microRNA-9 in hepatocellular carcinoma Y Liu, H Liu, L Yang, Q Wu, W Liu, Q Fu, W Zhang, H Zhang, J Xu, J Gu Journal of Biological Chemistry 292 (8), 3186-3200, 2017 | 36 | 2017 |
| Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2 S Wang, Y Zhu, H He, J Liu, L Xu, H Zhang, H Liu, W Liu, Y Liu, D Pan, ... Cancer science 104 (6), 750-759, 2013 | 31 | 2013 |
| Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection H Liu, W Liu, Z Liu, Y Liu, W Zhang, L Xu, J Xu Tumor Biology 36, 5039-5049, 2015 | 30 | 2015 |
| Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma Y Liu, Z Liu, Q Fu, Z Wang, H Fu, W Liu, Y Wang, J Xu Urologic Oncology: Seminars and Original Investigations 35 (6), 349-355, 2017 | 28 | 2017 |
| Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma W Liu, Y Liu, Q Fu, L Zhou, Y Chang, L Xu, W Zhang, J Xu Oncotarget 7 (12), 13976, 2016 | 28 | 2016 |
| High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma H An, L Xu, Y Zhu, T Lv, W Liu, Y Liu, H Liu, L Chen, J Xu, Z Lin British journal of cancer 110 (9), 2261-2268, 2014 | 28 | 2014 |
| Tumor suppressive function of p21-activated kinase 6 in hepatocellular carcinoma W Liu, Y Liu, H Liu, W Zhang, Q Fu, J Xu, J Gu Journal of Biological Chemistry 290 (47), 28489-28501, 2015 | 26 | 2015 |
| The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer W Liu, KP Newhall, F Khani, LM Barlow, D Nguyen, L Gu, K Eng, ... Cancer Research 83 (4), 506-520, 2023 | 23 | 2023 |
| p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma W Liu, Y Yang, Y Liu, H Liu, W Zhang, L Xu, Y Zhu, J Xu Urologic Oncology: Seminars and Original Investigations 33 (5), 205. e13-205 …, 2015 | 16 | 2015 |
| GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma Y Liu, W Liu, L Xu, H Liu, W Zhang, Y Zhu, J Xu, J Gu The Journal of urology 192 (5), 1534-1541, 2014 | 16 | 2014 |
